Overview

Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
To estimate the pharmacokinetics of apixaban when administered as three different modified release formulation tablets relative to that when apixaban is administered as an immediate release tablet
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Collaborator:
Bristol-Myers Squibb
Treatments:
Apixaban